4.6 Review

Can inflammasomes promote the pathophysiology of glioblastoma multiforme? A view about the potential of the anti-inflammasome therapy as pharmacological target

Journal

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 172, Issue -, Pages -

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2022.103641

Keywords

Glioblastoma; Human cancers; Tumor microenvironment; Immunologic response; Inflammasome; Exosome; Therapeutic; Therapeutic targets

Funding

  1. Institutional Technological Devel-opment and Innovation Initiation Scholarship Program
  2. Brazilian National Council for Scientific and Technological Develop-ment (Brazil)
  3. Foundation for Research Support of the State of Alagoas (Brazil)
  4. Federal University of Alagoas (Brazil)

Ask authors/readers for more resources

Glioblastoma multiforme is a malignant brain tumor with low survival rates due to its complex molecular heterogeneity and genetics. Current treatments are not effective, leading to the exploration of new approaches such as immunotherapy and the inflammasome pathway.
Glioblastoma multiforme (GBM) is a malignant brain tumor with one of the worst general survivorship cases among the existing neoplasia. This aggressiveness is due to its complex molecular heterogeneity, immunohistochemistry and genetics. The current therapeutic approach brings little contribution to the improvement of the survival of the patients. Due to that, new forms of treatment have been explored, one of them being immunotherapy. In this aspect, the inflammasome pathway, which induces inflammation and immunosuppressive tumor response, contributing to the progression of the tumor, seems to be a new alternative to improve the treatment efficacy and the survival of the patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Medicinal

Synthesis, Antileishmanial Activity and In Silico Studies of Aminoguani- dine Hydrazones (AGH) and Thiosemicarbazones (TSC) Against Leishma- nia chagasi Amastigotes

Thiago M. de Aquino, Paulo H. B. Franca, Erica E. E. S. Rodrigues, Igor J. S. Nascimento, Paulo F. S. Santos-Junior, Pedro G. Aquino, Mariana S. Santos, Aline C. Queiroz, Morgana Araujo, Magna S. Alexandre-Moreira, Raiza R. L. Rodrigues, Klinger A. F. Rodrigues, Johnnatan D. Freitas, Jacques Bricard, Mario R. Meneghetti, Jean-Jacques Bourguignon, Martine Schmitt, Edeildo F. da Silva-Junior, Joao X. de Araujo-Junior

Summary: This study aimed to address the side effects and drug resistance issues in the treatment of leishmaniasis by designing and synthesizing different compounds and performing screening for their antileishmanial activity and cytotoxicity. The study found that certain compounds showed potential antileishmanial activity and inhibitory effects on trypanothione reductase of the amastigote forms.

MEDICINAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

Antarctic environments as a source of bacterial and fungal therapeutic enzymes

Igor G. O. Lima, James R. S. Bispo, Adson Y. H. Agostinho, Aline C. De Queiroz, Magna Suzana A. Moreira, Michel Rodrigo Z. Passarini, Valeria M. De Oliveira, Lara D. Sette, Luiz Henrique Rosa, Alysson Wagner F. Duarte

Summary: This review explores the potential and unique characteristics of enzymes synthesized by Antarctic bacteria and fungi as potential drug producers, highlighting their importance in providing therapeutic efficacy, reducing side effects, and lowering production costs.

ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2022)

Article Cell Biology

LASSBio-596: a New Pre-clinical Candidate for Rheumatoid Arthritis?

Max Denisson Mauricio Viana, Alyne Almeida de Lima, Geraldo Jose da Silva Neto, Suellen Maria Albuquerque da Silva, Anderson Brandao Leite, Elane Conceicao dos Santos, Enio Jose Bassi, Eliane Aparecida Campesatto, Aline Cavalcanti de Queiroz, Eliezer Jesus Barreiro, Lidia Moreira Lima, Magna Suzana Alexandre-Moreira

Summary: Pain and inflammatory disorders are common health problems that can cause disabilities. LASSBio-596, a hybrid compound, has been found to have anti-inflammatory effects by modulating TNF-alpha and phosphodiesterases 4 and 5 in a pulmonary inflammatory model. Through various tests, it was demonstrated that LASSBio-596 can inhibit pain and inflammation, specifically reducing paw edema in arthritis and decreasing serum levels of TNF-alpha.

INFLAMMATION (2022)

Article Dentistry, Oral Surgery & Medicine

Identification of potential biomarkers and survival analysis for oral squamous cell carcinoma: A transcriptomic study

Daniela Paola Santos de Paula Souza, Lorena dos Reis Pereira Queiroz, Marcela Goncalves de Souza, Sabrina Ferreira de Jesus, Emisael Stenio Batista Gomes, Rogerio Trancoso Vitorino, Sergio Henrique Sousa Santos, Lucyana Conceicao Farias, Alfredo Mauricio Batista de Paula, Marcos Flavio Silveira Vasconcelos D'Angelo, Carlos Alberto de Carvalho Fraga, Andre Luiz Sena Guimaraes

Summary: By analyzing differentially expressed genes, we found that CSTA, FGFR2, MMP19, OLR1, PCSK1, RAMP2, and CGB5 are associated with a low survival rate in OSCC and may serve as potential prognostic factors for OSCC survival.

ORAL DISEASES (2023)

Article Pharmacology & Pharmacy

LQM10, a guanylhydrazone derivative, reduces nociceptive and inflammatory responses in mice

Joao Paulo Noe, Jamylle Nunes De Souza-Ferro, Erica Erlanny Da Silva-Rodrigues, Edeildo Ferreira Da Silva-Junior, Magna Suzana Alexandre-Moreira, Joao Xavier De Araujo-Junior, Emiliano Barreto

Summary: In this study, a compound called LQM10 was found to have antinociceptive and anti-inflammatory effects in mice. LQM10 reduced nociceptive behavior in certain pain models and inhibited inflammatory responses in carrageenan-induced pleurisy. These results suggest that LQM10 has potential as a treatment for pain and inflammation by acting on peripheral mechanisms and reducing leucocyte migration and proinflammatory mediators.

FUNDAMENTAL & CLINICAL PHARMACOLOGY (2023)

Article Parasitology

New immunodiagnostic methods for human tegumentary leishmaniasis in the last 10 years: Technological prospecting

Lilyana Waleska Nunes Albuquerque, Shakira Cavalcante de Albuquerque Ferreira, Marcio Thomaz dos Santos Varja, Amanda Evelyn da Silva, Alysson Wagner Fernandes Duarte, Glauber T. Silva, Magna Suzana Alexandre-Moreira, Aline Cavalcanti de Queiroz

Summary: This study conducts a patent prospection of immunodiagnostic methods for human tegumentary leishmaniasis in the last 10 years, focusing on those with high sensitivity and specificity, and simple usability. Eleven patents were found that satisfy the search criteria, with six of them being registered in 2017. Most patents were registered in Brazil. The obtained information covers the main characteristics of the evaluated immunodiagnostic methods. Moreover, no patent for immunodiagnostic methods was found in the last three years, raising concerns about the present and future trends of leishmaniasis diagnosis.

ACTA TROPICA (2023)

Article Microbiology

Bioprospecting the potential of the microbial community associated to Antarctic marine sediments for hydrocarbon bioremediation

Layssa de Melo Carlos, Karine Fernandes Camacho, Alysson Wagner Duarte, Valeria M. de Oliveira, Marcela Boroski, Luiz Henrique Rosa, Rosemary Vieira, Arthur A. Neto, Julia Ronzella Ottoni, Michel R. Z. Passarini

Summary: Microorganisms in the cold Antarctic environment have the potential to produce ligninolytic enzymes that can be used in bioremediation. This study characterized bacteria and fungi from marine sediment samples from King George and Deception Islands in Antarctica, which may be affected by hydrocarbon pollution and able to produce enzymes for bioremediation processes. Certain isolates showed tolerance to diesel oil and gasoline, as well as enzymatic activities for dye degradation. Taxonomic characterization identified two isolates (Psychrobacter sp. BAD17 and Cladosporium sp. FAR18) with better biotechnological results, exhibiting pyrene tolerance and laccase enzymatic activity. These findings suggest that bacteria and fungi in sediments under potential hydrocarbon pollution can be used to bioremediate cold environments contaminated with petroleum derivatives and dyes.

BRAZILIAN JOURNAL OF MICROBIOLOGY (2023)

Article Microbiology

Unravelling the genetic potential for hydrocarbon degradation in the sediment microbiome of Antarctic islands

Jessica B. Silva, Victor B. Centurion, Alysson W. F. Duarte, Rodrigo M. Galazzi, Marco A. Z. Arruda, Adilson Sartoratto, Luiz H. Rosa, Valeria M. Oliveira

Summary: This study investigated the genetic potential of Antarctic soil microorganisms for hydrocarbon degradation, and found that the abundant hydrocarbon-degrading genes in Antarctic sediments were mainly affiliated with Proteobacteria and Actinobacteria. The study also revealed that hydrocarbon input in Antarctic soils may come from both anthropogenic and natural sources.

FEMS MICROBIOLOGY ECOLOGY (2022)

Review Multidisciplinary Sciences

Antarctic organisms as a source of antimicrobial compounds: a patent review

Mauricio B. Silva, Alexya O. Feitosa, Igor G. O. Lima, James R. S. Bispo, Ana Caroline M. Santos, Magna S. A. Moreira, Paulo E. A. S. Camara, Luiz Henrique Rosa, Valeria M. Oliveira, Alysson W. F. Duarte, Aline C. Queiroz

Summary: Antimicrobial resistance is a global public health issue, and the exploration of Antarctic organisms could be a valuable source of new antimicrobial compounds. Despite the limited number of patent documents currently available, there is a wide variety of antimicrobial compounds present in Antarctic biota, which show potential for combating important human pathogens.

ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2022)

Review Oncology

cGAS-STING at the crossroads in cancer therapy

Rui Wang, Aashiq Hussain, Quanquan Guo, Meimei Ma

Summary: DNA is highly immunogenic and can activate the cGAS-STING pathway, which plays a crucial role in the pathogenesis and progression of neoplastic diseases. The modulation of cGAS-STING signaling holds great promise for cancer therapy, although there are disagreements on whether to activate or inhibit this pathway.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2024)

Review Oncology

Interleukin-1 receptor accessory protein (IL-1RAP): A magic bullet candidate for immunotherapy of human malignancies

Ali Zarezadeh Mehrabadi, Faezeh Shahba, Hossein Khorramdelazad, Nazanin Aghamohammadi, Milad Karimi, Kowsar Bagherzadeh, Majid Khoshmirsafa, Ramin Massoumi, Reza Falak

Summary: IL-1 receptor accessory protein (IL-1RAP) plays a crucial role in inflammatory conditions and tumorigenesis in the tumor microenvironment. It is involved in the progression, metastasis, and angiogenesis of solid tumors and hematological malignancies.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2024)

Review Oncology

Potential applications of ferroptosis inducers and regulatory molecules in hematological malignancy therapy

Xiao Tang, Yujie Niu, Jinli Jian, Yuancheng Guo, Yin Wang, Yu Zhu, Bei Liu

Summary: Ferroptosis is an iron-dependent form of cell death that promotes tumor cell death by causing cell membrane rupture and accumulation of lipid peroxides. Extensive research has been conducted to explore the mechanism of ferroptosis inducers, but its role in hematological tumors is still limited.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2024)

Review Oncology

CpG-biomarkers in tumor tissue and prediction models for the survival of colorectal cancer: A systematic review and external validation study

Tanwei Yuan, Dominic Edelmann, Jakob N. Kather, Ziwen Fan, Katrin E. Tagscherer, Wilfried Roth, Melanie Bewerunge-Hudler, Alexander Brobeil, Matthias Kloor, Hendrik Blaeker, Barbara Burwinkel, Hermann Brenner, Michael Hoffmeister

Summary: The study aimed to analyze and validate previously published CpG-methylation-based prognostic biomarkers and prediction models for colorectal cancer (CRC) prognosis. The results showed that the discrimination ability of the models was insufficient and lacked clinical relevance.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2024)

Review Oncology

Advances, opportunities and challenges in developing therapeutic cancer vaccines

Zhihui Duan, Dandan Yang, Ping Yuan, Xiaoming Dai, Guodong Chen, Daichao Wu

Summary: This article provides a comprehensive overview of therapeutic cancer vaccines, including their classification, clinical application, efficacy, and combination strategies with other therapies. It offers a valuable theoretical basis for the future clinical application and development of therapeutic cancer vaccines.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2024)